- Programs & Services
- Cost Management
- Specialty Management
- Care Management
- Member Engagement
- Health Plan Client Engagement
Shirisha Reddy, MD, Medical Director, Enterprise Oncology Solutions, CVS Health
Cancer management is complicated and increasingly expensive. Total cost of care is increasing by an average of 12 percent annually, with about 20 new drug approvals each year. Increasingly, gene therapies — such as CAR-T therapies that are being tested on multiple tumors — will bring welcome cures but also will continue to drive cost. The value of these therapies must be evaluated thoughtfully because cancer treatment can be as financially toxic as it is physically toxic.